CD8A and melanoma: EVs from head and neck squamous cell carcinoma and melanoma contained FasL and MHC class I molecules and significantly inhibit the expansion of primary-activated CD8+ T cells; consistent with these findings, authors showed that tumor EVs induce CD8+ Jurkat cells death [56].